Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer
Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer have?
Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer has 3,066 citations in the OpenAlex counts ScholarIQ stores.
When was Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer published?
Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer has 2007 year in the ScholarIQ index.
What is the open-access status of Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer?
Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer has bronze oa status in the ScholarIQ index.
What is the DOI of Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer?
The DOI for Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer is on the source record.
What is the PMID of Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer?
The PMID for Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer is on the source record.
What is the OpenAlex record for Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer?
The OpenAlex for Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer is on the source record.